SOUTH SAN FRANCISCO, Calif.--(EON: Enhanced Online News)--Fluidigm Corporation (NASDAQ:FLDM) will report its third quarter 2013 financial results on October 30, 2013, after close of market.
Gajus Worthington, Fluidigm president and chief executive officer, and Vikram Jog, chief financial officer, will host a conference call at 2:00 p.m. PDT (5:00 p.m. EDT) on October 30, 2013, to discuss third quarter 2013 financial results and operating activities. A press release outlining the financial results will be publicly distributed prior to the call.
The Fluidigm conference call can be accessed by calling (877) 556-5248 (domestic toll-free) or (720) 545-0029 (international toll). There will be a Q&A period during the call.
Fluidigm will also provide a live stream of its Q3 2013 financial results conference call for investors at: http://investors.fluidigm.com/events.cfm. The link will not be active until 1:45 p.m. PDT on October 30, 2013.
A telephone replay of the teleconference will be available 90 minutes after the end of the call at (855) 859-2056 (domestic toll-free), or (404) 537-3406 (international toll), access code 74412882. The conference call will also be archived on the Fluidigm investor’s page at: http://investors.fluidigm.com.
Fluidigm (NASDAQ:FLDM) develops, manufactures, and markets microfluidic systems to leading academic institutions, clinical laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology companies in growth markets, such as single-cell genomics, applied genotyping, and sample preparation for targeted resequencing. Fluidigm’s proprietary microfluidic systems consist of instruments and consumables, including 13 different commercial integrated fluidic circuits for nucleic acid analysis, and three families of assay chemistries. These systems are designed to significantly simplify experimental workflow, increase throughput, and reduce costs, while providing the excellent data quality demanded by customers. Fluidigm products are provided: For Research Use Only. Not for use in diagnostic procedures.
For more information, please visit www.fluidigm.com.
Fluidigm and the Fluidigm logo are trademarks or registered trademarks of Fluidigm Corporation.